辛伐他汀通过氧化应激减轻蒽环类药物心脏毒性的相关性研究
摘要
关键词
全文:
PDF参考
[1] Sheibani M,Azizi Y,Shayan M,et al. Doxorubicin-Induced Cardiotoxicity:An Overview on Pre-clinical Therapeutic Approaches[J].Cardiovasc Toxicol,2022,22(4):292-310.
[2] Christidi E, Brunham L R. Regulated cell death pathways in doxorubicin-induced cardiotoxicity [J]. Cell Death Dis, 2021,12(4):339.
[3] Kong C Y,Guo Z,Song P,et al.Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity:Oxidative Stress and Cell Death[J]. Int J Biol Sci,2022,18(2):760-770.
[4] Chotenimitkhun R,D'agostino R,Jr.,Lawrence J A,et al.Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function[J].Can J Cardiol, 2015,31(3):302-7.
[5] Sawicki K T,Sala V,Prever L,et al.Preventing and Treating Anthracycline Cardiotoxicity:New Insights[J].Annu Rev Pharmacol Toxicol,2021,61: 309-332.
[6] Wei M F,Cheng C H,Wen S Y,et al. Atorvastatin Attenuates Radiotherapy-Induced Intestinal Damage through Activation of Autophagy and Antioxidant Effects[J].Oxid Med Cell Longev,2022,2022:7957255.
[7] Cappetta D,De Angelis A,Sapio L,et al.Oxidative Stress and Cellular Response to Doxorubicin:A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity[J].Oxid Med Cell Longev,2017,2017:1521020.
[8] Patel R,Nagueh S F,Tsybouleva N,et al.Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy[J].Circulation,2001, 104(3):317-24.
[9] Kim M J,Bible K L,Regnier M,et al. Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy[J].Physiol Rep,2019,7(6): e14018.
[10]Bjørnstad R,Reiten I N, Knudsen K S,et al. A liposomal formulation of simvastatin and doxorubicin for improved cardioprotective and anti-cancer effect [J].Int J Pharm,2022,629:122379.
(3 摘要 Views, 13 PDF Downloads)
Refbacks
- 当前没有refback。